The present invention provides compounds, pharmaceutical compositions, and methods that can be used to treat pathologies that are due to copper overload or to the presence of reactive oxygen species.

 
Web www.patentalert.com

< siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

> Protein Kinase Targeted Therapeutics

> ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITORS
~ 00572